Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on InteliCare.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: The reason people quit weight-loss drugs
Health & Biotech
Check Up: Introducing the Brain Atlas, the largest map of the human brain. And recent ASX biotech winners
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: A happy pharma debutante, plus positive news for a bunch of explorers
Health & Biotech
InteliCare inks multi-million dollar binding reseller agreement and aged care deployment
News
Top 10 at 11: There’s movement on the market, but not much news to explain why
Health & Biotech
ASX Health Winners: Biotechs up 10pc in November, and Janus Henderson’s prediction for 2024
Health & Biotech
Check Up: Imugene’s oncolytic virus VAXINIA granted FDA’s Fast Track, but how effective is this novel therapy?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Smug ASX ends Tuesday higher, but not much better
News
In Case You Missed It: AI-aged care deal, EV bank loans and some rare earths
Tech
InteliCare signs MoU with aged care giant Bolton Clarke
News
Small Cap Lunch Wrap: Grab a spoon. Plenti to share ‘cos its All You Can Eat Tuesday on the ASX
News
Top 10 at 10: Special EV loans, M&A, and a big Brazil REE buy
News
Market Highlights: Retail stocks in focus, VIX fear index lowest since 2020, and 5 ASX small caps to watch
Health & Biotech
InteliCare (ASX:ICR) enters healthcare sector announcing Remote Patient Monitoring pilot with leading cancer center
Health & Biotech